Bill L. Tranum

536 total citations
20 papers, 427 citations indexed

About

Bill L. Tranum is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bill L. Tranum has authored 20 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bill L. Tranum's work include Cancer Treatment and Pharmacology (9 papers), Breast Cancer Treatment Studies (7 papers) and Acute Myeloid Leukemia Research (2 papers). Bill L. Tranum is often cited by papers focused on Cancer Treatment and Pharmacology (9 papers), Breast Cancer Treatment Studies (7 papers) and Acute Myeloid Leukemia Research (2 papers). Bill L. Tranum collaborates with scholars based in United States and Egypt. Bill L. Tranum's co-authors include Arthur Haut, Susan E. Bates, James Y. Suen, Barth Hoogstraten, Clarence B. Vaughn, Thomas R. Maloney, Saul E. Rivkin, John J. Costanzi, J. W. Athens and Shelley L. Rasmussen and has published in prestigious journals such as Cancer, CHEST Journal and Transfusion.

In The Last Decade

Bill L. Tranum

20 papers receiving 364 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Bill L. Tranum 233 140 100 57 55 20 427
F Turpin 247 1.1× 85 0.6× 68 0.7× 39 0.7× 25 0.5× 35 410
S Schryber 258 1.1× 107 0.8× 77 0.8× 143 2.5× 33 0.6× 9 435
W. Mattsson 271 1.2× 60 0.4× 75 0.8× 18 0.3× 38 0.7× 29 474
J. Crawford 271 1.2× 85 0.6× 173 1.7× 86 1.5× 25 0.5× 43 518
M. Varini 319 1.4× 201 1.4× 184 1.8× 62 1.1× 49 0.9× 18 646
U. Klaassen 642 2.8× 203 1.4× 130 1.3× 51 0.9× 28 0.5× 31 777
JN Ingle 270 1.2× 137 1.0× 47 0.5× 51 0.9× 14 0.3× 27 413
Pankaj Khandelwal 396 1.7× 230 1.6× 115 1.1× 16 0.3× 35 0.6× 10 556
Carbone Pp 270 1.2× 54 0.4× 170 1.7× 53 0.9× 30 0.5× 28 548
J.P. Bergerat 192 0.8× 103 0.7× 88 0.9× 12 0.2× 20 0.4× 29 318

Countries citing papers authored by Bill L. Tranum

Since Specialization
Citations

This map shows the geographic impact of Bill L. Tranum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bill L. Tranum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bill L. Tranum more than expected).

Fields of papers citing papers by Bill L. Tranum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bill L. Tranum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bill L. Tranum. The network helps show where Bill L. Tranum may publish in the future.

Co-authorship network of co-authors of Bill L. Tranum

This figure shows the co-authorship network connecting the top 25 collaborators of Bill L. Tranum. A scholar is included among the top collaborators of Bill L. Tranum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bill L. Tranum. Bill L. Tranum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saiki, John H., et al.. (1993). Mitoxantrone (dihydroxyanthracenedione) in acute leukemia. Investigational New Drugs. 11(2-3). 197–200. 1 indexed citations
2.
Karanes, Chatchada, John Crowley, Bill L. Tranum, et al.. (1990). Aclacinomycin A in the treatment of multiple myeloma: A Southwest Oncology Group study. Investigational New Drugs. 8(1). 101–104. 3 indexed citations
3.
4.
Dana, Bruce W., Steve Dahlberg, Bertram Schnitzer, et al.. (1989). Mitoxantrone, cisplatin, and methyl-glyoxal bis-guanylhydrazone chemotherapy for refractory malignant lymphoma: A Southwest Oncology Group phase II trial. Investigational New Drugs. 7(2-3). 247–250. 3 indexed citations
5.
Livingston, Robert B., Susan Schulman, Brian R. Griffin, et al.. (1987). Combination chemotherapy and systemic irradiation consolidation for poor prognosis breast cancer. Cancer. 59(7). 1249–1254. 23 indexed citations
6.
Hilgers, Robert D., Sewa S. Legha, David S. Alberts, et al.. (1984). m-AMSA and adenocarcinoma of the endometrium. Investigational New Drugs. 2(3). 335–338. 3 indexed citations
7.
Hoogstraten, Barth, Thomas R. Maloney, William S. Fletcher, et al.. (1984). Combined modality therapy for first recurrence of breast cancer. A Southwest Oncology Group Study. Cancer. 54(10). 2248–2256. 35 indexed citations
8.
Knight, William A., Daniel D. Von Hoff, James A. Neidhart, et al.. (1983). Mitoxantrone in advanced breast cancer: a phase II trial of the Southwest Oncology Group. Investigational New Drugs. 1(2). 181–184. 10 indexed citations
9.
Weick, James K., Bill L. Tranum, & Francis S. Morrison. (1983). The treatment of acute leukemia with continuous infusion L-Alanosine. Investigational New Drugs. 1(3). 249–252. 7 indexed citations
10.
Glucksberg, Harold, Saul E. Rivkin, Shelley L. Rasmussen, et al.. (1982). Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes. A southwest oncology group study. Cancer. 50(3). 423–434. 58 indexed citations
11.
Tranum, Bill L., Brenna C. McDonald, Tate Thigpen, et al.. (1982). Adriamycin combinations in advanced breast cancer:A southwest oncology group study. Cancer. 49(5). 835–839. 37 indexed citations
12.
Bates, Susan E. & Bill L. Tranum. (1982). Perfusion lung scan. An aid in detection of lymphangitic carcinomatosis. Cancer. 50(2). 232–235. 10 indexed citations
13.
Rasmussen, Shelley L., et al.. (1979). Phase II evaluation of hexamethylmelamine in advanced breast cancer: a Southwest Oncology Group study.. PubMed. 63(8). 1359–61. 9 indexed citations
14.
Bates, Susan E., James Y. Suen, & Bill L. Tranum. (1979). Immunological skin testing and interpretation. A plea for uniformity. Cancer. 43(6). 2306–2314. 48 indexed citations
15.
Tranum, Bill L., Barth Hoogstraten, Alexander Kennedy, et al.. (1978). Adriamycin in combination for the treatment of breast cancer.A southwest oncology group study. Cancer. 41(6). 2078–2083. 40 indexed citations
16.
Tranum, Bill L., et al.. (1977). Pulmonary Fibrosis after Prolonged Therapy with 1,3-Bis (2-chloroethyl)-nitrosourea. CHEST Journal. 72(3). 372–373. 22 indexed citations
17.
Tranum, Bill L., Ronald L. Stephens, Daniel E. Lehane, et al.. (1975). Adriamycin (NSC-123127) plus 5-fluorouracil (NSC-19893): a phase I study.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 59(6). 1163–5. 1 indexed citations
18.
Tranum, Bill L., Arthur Haut, Saul E. Rivkin, et al.. (1975). A phase II study of methyl CCNU in the treatment of solid tumors and lymphomas: A Southwest oncology group study. Cancer. 35(4). 1148–1153. 26 indexed citations
19.
Tranum, Bill L. & Arthur Haut. (1974). Thrombocytosis: platelet kinetics in neoplasia.. PubMed. 84(5). 615–9. 67 indexed citations
20.
Tranum, Bill L. & Arthur Haut. (1972). In Vivo Survival of Platelets Prepared in CPD Anticoagulant. Transfusion. 12(3). 168–174. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026